Christin Andersson

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 23:87-95. 2007
  2. ncbi Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, NOVUM Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Neurobiol Aging 29:1466-73. 2008
  3. ncbi Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients
    Christin Andersson
    Neurotec Department, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 21:251-9. 2006

Detail Information

Publications3

  1. ncbi Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 23:87-95. 2007
    ..To investigate the relationships between episodic memory, APOE genotype, CSF markers (total tau, T-tau; phospho-tau, P-tau; beta-amyloid, Abeta42) and longitudinal cognitive decline...
  2. ncbi Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, NOVUM Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Neurobiol Aging 29:1466-73. 2008
    ..Little is known about longitudinal changes of cerebrospinal fluid (CSF) biomarkers during cognitive decline in neurodegenerative disease progression...
  3. ncbi Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients
    Christin Andersson
    Neurotec Department, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 21:251-9. 2006
    ..To investigate whether application of cutoff levels in an episodic memory test (Rey Auditory Verbal Learning Test, RAVLT) is a useful method for identifying patients at high and low risk of cognitive decline and subsequent dementia...